Please assess the completion status of the following clinical trial:

Trial Title: Follow up of LEAP Participants and Their Families

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Inclusion Criteria - LEAP Participants:~* Participation in LEAP;~* At least 9.5 years of age~* Willingness to participate in at least one study data collection (i.e. questionnaire, skin pricking testing, or blood draw) procedure; and~* Assent by child and informed consent by parent or legal guardian.~Inclusion Criteria - LEAP Siblings:~* Sibling of LEAP participant;~* Willingness to participate in at least one study data collection (i.e. questionnaire, skin pricking testing, or blood draw); and~* Assent by child and informed consent by parent or legal guardian if child is younger than 16; siblings aged 16 and over will provide their own consent.~Inclusion Criteria - LEAP Parents:~* Biological parent of LEAP participant;~* Willingness to participate in at least one study data collection (i.e. questionnaire, skin pricking testing, or blood draw); and~* Informed consent (for participants only returning a Questionnaire, informed consent will be implied).~Exclusion Criteria:~* There are no exclusion criteria for LEAP Participants, LEAP Siblings, LEAP Parents

- Gender: ALL
- Minimum Age: 0 Months
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- LEAP Participants: Peanut Avoidance (Type: None): Participants of the LEAP study who enrolled in the LEAP Trio study and were originally randomized to the Peanut Avoidance treatment arm upon entry into the LEAP study.
- LEAP Participants: Peanut Consumption (Type: None): Participants of the LEAP study who enrolled in the LEAP Trio study and were originally randomized to the Peanut Consumption treatment arm upon entry into the LEAP study.
- Younger Siblings: Peanut Avoidance (Type: None): Participants enrolled in the LEAP Trio study who are younger siblings of a LEAP Participant who was randomized to the Peanut Avoidance treatment arm upon entry into the LEAP study.
- Younger Siblings: Peanut Consumption (Type: None): Participants enrolled in the LEAP Trio study who are younger siblings of a LEAP Participant who was randomized to the Peanut Consumption treatment arm upon entry into the LEAP study.
- Older Siblings: Peanut Avoidance (Type: None): Participants enrolled in the LEAP Trio study who are older siblings of a LEAP Participant who was randomized to the Peanut Avoidance treatment arm upon entry into the LEAP study.
- Older Siblings: Peanut Consumption (Type: None): Participants enrolled in the LEAP Trio study who are older siblings of a LEAP Participant who was randomized to the Peanut Consumption treatment arm upon entry into the LEAP study.
- Parents: Peanut Avoidance (Type: None): Participants enrolled in the LEAP Trio study who are parents of a LEAP Participant who was randomized to the Peanut Avoidance treatment arm upon entry into the LEAP study.
- Parents: Peanut Consumption (Type: None): Participants enrolled in the LEAP Trio study who are parents of a LEAP Participant who was randomized to the Peanut Consumption treatment arm upon entry into the LEAP study.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete